Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

CompletedOBSERVATIONAL
Enrollment

215

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

March 3, 2025

Study Completion Date

March 3, 2025

Conditions
Myasthenia GravisNeuromuscular ManifestationsNeuromuscular Diseases
Interventions
BEHAVIORAL

Social media recruitment

Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment

BEHAVIORAL

Self-Assessment

Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups

BEHAVIORAL

Follow-up

Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis

Trial Locations (1)

60201

ZS Associates, Evanston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

collaborator

University of California, San Francisco

OTHER

lead

ZS Associates

INDUSTRY